EBOS Group (NZSE:EBO) - Aktienkurs, Nachrichten und Analyse

EBO Aktienübersicht

Die EBOS Group Limited ist in Australien, Neuseeland und Südostasien in den Bereichen Marketing, Großhandel und Vertrieb von medizinischen, pharmazeutischen und Tierpflegeprodukten tätig.

Über das Unternehmen

EBO grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	4/6
Künftiges Wachstum	1/6
Vergangene Leistung	3/6
Finanzielle Gesundheit	5/6
Dividenden	3/6

Belohnungen

30.9% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 6.31% pro Jahr

Die Erträge sind in den letzten 5 Jahren um 13.7% pro Jahr gestiegen.

Risikoanalyse

Hat einen hohen Schuldenstand

EBOS Group Limited Wettbewerber

Summerset Group Holdings

NZSE:SUM

NZ$2.3b

Arvida Group

NZSE:ARV

NZ$694.4m

Fisher & Paykel Healthcare

NZSE:FPH

NZ$17.7b

Jointown Pharmaceutical Group

SHSE:600998

CN¥24.9b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für EBOS Group
Historische Aktienkurse
Aktueller Aktienkurs	NZ$32.39
52-Wochen-Hoch	NZ$38.60
52-Wochen-Tief	NZ$31.02
Beta	0.26
11 Monat Veränderung	-6.93%
3 Monate Veränderung	-9.02%
1 Jahr Veränderung	-11.98%
33 Jahre Veränderung	-0.64%
5 Jahre Veränderung	39.91%
Veränderung seit IPO	1,327.28%

Aktuelle Nachrichten und Updates

Recent updates

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

Jun 11

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

May 28

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Apr 25

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Mar 21

EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951

Feb 24

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

Feb 23

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

Jan 23

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Dec 18

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Nov 02

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

Oct 17

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

Oct 02

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Aug 02

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Jun 26

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

May 02

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Apr 14

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

Mar 14

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 26

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jan 06

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Nov 28

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

Oct 21

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

Oct 05

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Sep 13

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Aug 26

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

Jun 24

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

May 10

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Mar 17

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

Feb 26

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 18

EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price

Jan 22

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Dec 26

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

Oct 31

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued

Oct 18

Is EBOS Group (NZSE:EBO) A Risky Investment?

Sep 19

Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today

Aug 05

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jul 13

EBOS Group's (NZSE:EBO) Returns Have Hit A Wall

Jun 09

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

May 01

Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly

Apr 08

A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Mar 27

Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?

Mar 15

Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?

Mar 03

Analysts Are Updating Their EBOS Group Limited (NZSE:EBO) Estimates After Its Half-Year Results

Feb 19

Has EBOS Group (NZSE:EBO) Got What It Takes To Become A Multi-Bagger?

Feb 09

With EPS Growth And More, EBOS Group (NZSE:EBO) Is Interesting

Jan 27

EBOS Group (NZSE:EBO) Has Gifted Shareholders With A Fantastic 147% Total Return On Their Investment

Jan 14

Estimating The Fair Value Of EBOS Group Limited (NZSE:EBO)

Dec 26

Aktionärsrenditen

	EBO	NZ Healthcare	NZ Markt
7D	-0.3%	0.6%	-1.6%
1Y	-12.0%	-19.9%	-5.4%

Rendite im Vergleich zur Industrie: EBO übertraf die Branche NZ Healthcare , die im vergangenen Jahr eine Rendite von -22.7 erzielte.

Rendite vs. Markt: EBO hinter dem Markt NZ zurück, der im vergangenen Jahr eine Rendite von -5.1 erzielte.

Preisvolatilität

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement	3.6%
Healthcare Industry Average Movement	4.4%
Market Average Movement	4.3%
10% most volatile stocks in NZ Market	7.9%
10% least volatile stocks in NZ Market	2.9%

Stabiler Aktienkurs: EBO hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: EBODie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1922	5,000	John Cullity	www.ebosgroup.com

Die EBOS Group Limited ist in Australien, Neuseeland und Südostasien in den Bereichen Marketing, Großhandel und Vertrieb von medizinischen, pharmazeutischen und tiermedizinischen Produkten tätig. Das Unternehmen ist in den Segmenten Gesundheitswesen und Tierpflege tätig. Das Unternehmen bietet Logistik für das Gesundheitswesen, Lösungen für das Medikamentenmanagement, Software für das Apothekenmanagement, Dienstleistungen für Kundenbindung, Generika, Compliance, Business Intelligence und Filialsoftware sowie Kommunikations-, Programm- und Beratungsdienste für das Gesundheitswesen.

EBOS Group Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von EBOS Group im Vergleich zum Marktanteil des Unternehmens?
EBO grundlegende Statistiken
Marktanteil	NZ$6.26b
Gewinn(TTM)	NZ$279.56m
Umsatz(TTM)	NZ$13.77b

22.4x

Kurs-Gewinn-Verhältnis

0.5x

Kurs-Umsatz-Verhältnis

Ist EBO zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
EBO Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$12.67b
Kosten der Einnahmen	AU$11.09b
Bruttogewinn	AU$1.58b
Sonstige Ausgaben	AU$1.33b
Umsatz	AU$257.35m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

Aug 21, 2024

Gewinn per Aktie (EPS)	1.33
Bruttomarge	12.49%
Nettogewinnspanne	2.03%
Schulden/Eigenkapital-Verhältnis	62.3%

Wie hat sich EBO auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.5%

Aktuelle Dividendenrendite

78%

Ausschüttungsquote

EBO Aktienübersicht

Belohnungen

Risikoanalyse

EBOS Group Limited Wettbewerber

NZSE:SUM

NZ$2.3b

NZSE:ARV

NZ$694.4m

NZSE:FPH

NZ$17.7b

SHSE:600998

CN¥24.9b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

EBOS Group Limited Announces Chief Financial Officer Changes

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Insider recently sold NZ$5.3m worth of stock

Recent updates

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

EBOS Group Limited Announces Chief Financial Officer Changes

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Insider recently sold NZ$5.3m worth of stock

EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951

First half dividend of NZ$0.60 announced

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023)

EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 21% undervalued

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024

Now 21% undervalued

EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

Now 22% undervalued after recent price drop

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

EBOS Not to Proceed with Acquisition in Animal Care Segment

EBOS Not to Proceed with Acquisition in Animal Care Segment

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023

Now 20% undervalued

Upcoming dividend of NZ$0.60 per share at 3.0% yield

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Ebos Group Limited Announces Dividend, Payable on 29 September 2023

Full year 2023 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued after recent price drop

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.70 (vs AU$0.61 in 1H 2022)

EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Upcoming dividend of NZ$0.51 per share

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

Upcoming dividend of NZ$0.49 per share

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Erträge & Einnahmen